US6863886B2 - Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders - Google Patents

Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders Download PDF

Info

Publication number
US6863886B2
US6863886B2 US10/371,850 US37185003A US6863886B2 US 6863886 B2 US6863886 B2 US 6863886B2 US 37185003 A US37185003 A US 37185003A US 6863886 B2 US6863886 B2 US 6863886B2
Authority
US
United States
Prior art keywords
hyaluronidase
vitreous
treatment
eye
vitreous humor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US10/371,850
Other versions
US20030170224A1 (en
Inventor
Hampar Karageozian
Vicken Karageozian
Maria C. Kenney
Jose L. G. Flores
Gabriel Arturo Carpio Aragon
Anthony B. Nesburn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
ISTA Pharmaceuticals Inc
Original Assignee
Advanced Corneal Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/561,636 priority Critical patent/US5866120A/en
Priority to US86262097A priority
Priority to PCT/US1998/010578 priority patent/WO1998052602A1/en
Priority to US09/444,003 priority patent/US6610292B2/en
Priority to US10/371,850 priority patent/US6863886B2/en
Application filed by Advanced Corneal Systems Inc filed Critical Advanced Corneal Systems Inc
Publication of US20030170224A1 publication Critical patent/US20030170224A1/en
Application granted granted Critical
Publication of US6863886B2 publication Critical patent/US6863886B2/en
Assigned to BAUSCH & LOMB PHARMA HOLDINGS CORP. reassignment BAUSCH & LOMB PHARMA HOLDINGS CORP. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ISTA PHARMACEUTICALS, LLC
Assigned to GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT reassignment GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: BAUSCH & LOMB PHARMA HOLDINGS CORP.
Assigned to BARCLAYS BANK PLC, AS SUCCESSOR AGENT reassignment BARCLAYS BANK PLC, AS SUCCESSOR AGENT NOTICE OF SUCCESSION OF AGENCY Assignors: GOLDMAN SACHS LENDING PARTNERS, LLC
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links